Neola Medical AB (publ) (NEOLA.ST)
Neola Medical AB (publ) operates in the Medical - Devices industry of the Healthcare sector, headquartered in Lund, SN, SE. The stock last traded at $0.47, down 1.69% on the session, giving a market capitalisation of $51.5M. Its beta of 1.51 implies it has historically moved more than the broad market.
Neola Medical AB (publ) specializes in developing advanced medical devices for the continuous pulmonary assessment of premature babies. At the core of its offerings is NEOLA, a sophisticated medical instrument critical for neonatal intensive care. This device facilitates ongoing lung function monitoring and generates immediate alerts for critical, life-threatening complications. It achieves this by accurately tracking changes in lung volume and oxygen gas concentration. The ultimate goal of NEOLA is to enhance intensive care and promote healthier outcomes for infants born preterm. The company, formerly known as GPX Medical AB, officially changed its name to Neola Medical AB (publ) in June 2022. Neola Medical AB (publ) was established in 2016 and is headquartered in Lund, Sweden.
Neola Medical AB (publ) is most often compared with the following Healthcare names: